DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Retrospective studies have been conducted on dystrophinopathy patients at Aga Khan University Hospital Karachi utilizing MLPA to screen dystrophin gene exons for deletions/ duplications.11,12 But no study so far has focused on derivation of iPSCs from these patients for future invitro disease modeling.